In a bid to bolster its manufacturing capabilities, Syngene International has lined up $200 million capex over the next three years. The company will invest $100 million at a greenfield facility in Mangaluru, the first phase of which would be operationalised by financial year 2018-19. Besides, it has also earmarked another $100 million to create additional infrastructure at its existing facility at Bengaluru.
Syngene International offers discovery and development services for novel molecular entities (NMEs) across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition.
